Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Cureus|March 30, 2023
Oral Microbiome as a Tool of Systemic Disease on Cleft Patients: A New LandscapeVania Arboleda, Kawther N Elsouri, Samantha E Heiser, et al.
European Journal of Gastroenterology & Hepatology|March 26, 2003
Development of antinuclear antibodies and its clinical impact in patients with Crohn's disease treated with chimeric monoclonal anti-TNFalpha antibodies (infliximab)Esther Garcia-Planella, Eugeni Domènech, Maria Esteve-Comas, et al.
Digestive Diseases and Sciences|November 7, 2006
Medication-taking behavior in a cohort of patients with inflammatory bowel diseaseIsabel Bernal, Eugeni Domènech, Esther Garcia-Planella, et al.
European Journal of Immunology|May 12, 2018
Proteomic definition of human mucosal-associated invariant T cells determines their unique molecular effector phenotypeBjörn Bulitta, Werner Zuschratter, Isabel Bernal, et al.
Journal of Gastroenterology and Hepatology|March 18, 2014
Addition of mesalazine for subclinical post-surgical endoscopic recurrence of Crohn's disease despite preventive thiopurine therapy: A case-control studyYamile Zabana, Míriam Mañosa, Eduard Cabré, et al.
Digestive Diseases and Sciences|July 27, 2006
Predictors of clinical response to systemic steroids in active ulcerative colitisIsabel Bernal, Míriam Mañosa, Eugeni Domènech, et al.
Inflammatory Bowel Diseases|April 8, 2011
Decision tree for early introduction of rescue therapy in active ulcerative colitis treated with steroidsMíriam Mañosa, Eduard Cabré, Esther Garcia-Planella, et al.
Plos One|December 17, 2013
Consumption of Lactobacillus casei fermented milk prevents Salmonella reactive arthritis by modulating IL-23/IL-17 expressionMariángeles Noto Llana, Sebastián Hernán Sarnacki, María del Rosario Aya Castañeda, et al.
Frontiers in Microbiology|November 10, 2018
<i>Clostridioides difficile</i> Activates Human Mucosal-Associated Invariant T CellsIsabel Bernal, Julia Danielle Hofmann, Björn Bulitta, et al.
Pageof 6